3 2 Kaloo Medical Ltd 12624144 false 2023-06-01 2024-05-31 2024-05-31 The principal activity of the company is medical practitioners Digita Accounts Production Advanced 6.30.9574.0 true 12624144 2023-06-01 2024-05-31 12624144 2024-05-31 12624144 bus:Director1 1 2024-05-31 12624144 bus:OrdinaryShareClass1 bus:OtherShareType 2024-05-31 12624144 core:RetainedEarningsAccumulatedLosses 2024-05-31 12624144 core:ShareCapital 2024-05-31 12624144 core:CurrentFinancialInstruments 2024-05-31 12624144 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 12624144 core:MotorVehicles 2024-05-31 12624144 core:OfficeEquipment 2024-05-31 12624144 bus:SmallEntities 2023-06-01 2024-05-31 12624144 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 12624144 bus:FilletedAccounts 2023-06-01 2024-05-31 12624144 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 12624144 bus:RegisteredOffice 2023-06-01 2024-05-31 12624144 bus:Director1 2023-06-01 2024-05-31 12624144 bus:Director1 1 2023-06-01 2024-05-31 12624144 bus:Director2 2023-06-01 2024-05-31 12624144 bus:OrdinaryShareClass1 bus:OtherShareType 2023-06-01 2024-05-31 12624144 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 12624144 bus:Agent1 2023-06-01 2024-05-31 12624144 core:ComputerEquipment 2023-06-01 2024-05-31 12624144 core:MotorVehicles 2023-06-01 2024-05-31 12624144 core:OfficeEquipment 2023-06-01 2024-05-31 12624144 core:Vehicles 2023-06-01 2024-05-31 12624144 countries:UnitedKingdom 2023-06-01 2024-05-31 12624144 2023-05-31 12624144 bus:Director1 1 2023-05-31 12624144 core:MotorVehicles 2023-05-31 12624144 core:OfficeEquipment 2023-05-31 12624144 2022-06-01 2023-05-31 12624144 2023-05-31 12624144 bus:Director1 1 2023-05-31 12624144 bus:OrdinaryShareClass1 bus:OtherShareType 2023-05-31 12624144 core:RetainedEarningsAccumulatedLosses 2023-05-31 12624144 core:ShareCapital 2023-05-31 12624144 core:CurrentFinancialInstruments 2023-05-31 12624144 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 12624144 bus:Director1 1 2022-06-01 2023-05-31 12624144 bus:Director1 1 2022-05-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 12624144

Kaloo Medical Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 May 2024

 

Kaloo Medical Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Kaloo Medical Ltd

Company Information

Directors

Dr P D Kaloo

Dr C Kaloo

Registered office

111-113 High Street
Evesham
Worcestershire
WR11 4XP

Accountants

Clement Rabjohns Limited
Chartered Accountants 111/113 High Street
Evesham
Worcestershire
WR11 4XP

 

Kaloo Medical Ltd

(Registration number: 12624144)
Balance Sheet as at 31 May 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

17,770

-

Current assets

 

Debtors

5

1,665

5,449

Cash at bank and in hand

 

1,082

768

 

2,747

6,217

Creditors: Amounts falling due within one year

6

(9,109)

(2,155)

Net current (liabilities)/assets

 

(6,362)

4,062

Net assets

 

11,408

4,062

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

11,308

3,962

Shareholders' funds

 

11,408

4,062

For the financial year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 21 February 2025 and signed on its behalf by:
 

.........................................
Dr P D Kaloo
Director

 

Kaloo Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
111-113 High Street
Evesham
Worcestershire
WR11 4XP
United Kingdom

These financial statements were authorised for issue by the Board on 21 February 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Kaloo Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicles

18.00% reducing balance

Computer equipment

33.33% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Kaloo Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2023 - 2).

 

Kaloo Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

4

Tangible assets

Office equipment
£

Motor vehicles
 £

Total
£

Cost or valuation

At 1 June 2023

1,198

-

1,198

Additions

-

21,670

21,670

At 31 May 2024

1,198

21,670

22,868

Depreciation

At 1 June 2023

1,198

-

1,198

Charge for the year

-

3,900

3,900

At 31 May 2024

1,198

3,900

5,098

Carrying amount

At 31 May 2024

-

17,770

17,770

5

Debtors

Current

2024
£

2023
£

Prepayments

1,665

-

Other debtors

-

5,449

 

1,665

5,449

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Taxation and social security

7,275

955

Accruals and deferred income

1,834

1,200

9,109

2,155

 

Kaloo Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

       

8

Related party transactions

Transactions with directors

2024

At 1 June 2023
£

Repayments by director
£

At 31 May 2024
£

Dr P D Kaloo

Director's loan account repayble on demand, interest charged at offical rate

5,449

5,449

-

2023

At 1 June 2022
£

Advances to director
£

At 31 May 2023
£

Dr P D Kaloo

Director's loan account repayble on demand, interest charged at offical rate

-

5,449

5,449